Karakteristik Pasien Diabetes Melitus tipe 2 dengan Tinea Korporis di SMF Ilmu Kesehatan Kulit dan Kelamin RSUP. H. Adam Malik Medan Periode Januari 2010 – Desember 2012
35
DAFTAR PUSTAKA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Perkumpulan Endokrinologi
Indonesia. Konsensus pengelolaan dan
pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PB PERKENI;
2008. h. 4-27.
Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan
Republik Indonesia. Riset Kesehatan Dasar 2007. Jakarta : Departemen
kesehatan RI; 2008
American Diabetes Association, 2004, Diabetes Complications,
www.diabetesjournals.org, 27:1506 – 1514, 8 Maret 2006
Eckhard M, Lenger A, Liersch J, Bretzel RG, Mayser P. Fungal foot
infection in patients with diabetes melitus-results of two independent
investigations. Mycoses 2007; 50 (Suppl. 2): 14-9.
Wani MA, Hassan I, Hayat BM, Ahmed QM. Cutaneus manifestation of
diabetes melitus : A hospital based study in kashmir, India. Edog 2009; 5(2).
Bristow I. Non-ulserative skin pathologies of diabetic foot. Diabetes Metab
Res Rev 2008; 24(Suppl 1): S84–9.
Hadad. Prevalence of cutaneus manifestaion of diabetes melitus. J Ayub
Med Coll Abbottabad 2009; 21(2).
Nasren S, Ahmed I, Jahangir MU. Cutaneus manifestations of diabetic foot.
Journal of pakistan association of dermatologists 2009; 19: 13-7.
Drozdowska A, Drzewoski J. Mycoses in diabetes—Difficult diagnostic and
therapeutic problem. Viamedica 2008; 8(1): 1-11.
Goodall I. HbA1c Standardisation destination—global IFCC standardisation
how, why, where and when. Clin Biochem Rev 2005; 26 (1).
Foss, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J
Am Acad Dermatol 1992; 26: 408-10
Nitin S. HbA1c and factors other than diabetes mellitus affecting. Singapore
Med J 2010; 51(8):616.
Suryaatmaja M. Standarisasi dan harmonisasi pemeriksaan HbA1c. Dalam:
Pendidikan berkesinambungan Patologi klinik 2010. Jakarta: Balai Penerbit
FK UI; 2010. h. 92-104.
Bristow RI, Spruce MC. Short report fungal foot infection, cellulitis and
diabetes : a review. Diabetic Medicine 2009; 26: 548–51.
Akbar N, Bilal N. The sweet foot relation of glycemic control with diabetic
foot lesion. International journal of pathology 2004; 2(2): 90-3.
Haddad F, Khawaldeh AK, Ababneh H, Mai O. Pattern of bacteria and
fungi growth in the non-insulin dependent diabetes melitus toe webs.
Bahrain Med Bull 2008; 20(1): 5-8.
Budi U. Mikosis. Dalam: Djuanda A, Hamzah M, Aisah S, editor. Ilmu
penyakit kulit dan kelamin. Edisi ke-5. Balai Penerbit Fakultas kedokteran
Universitas Indonesia; 2007. h.106-9.
Hay RJ, Moore J. Mycology. Dalam : Burn T, Breathnach S, Cox N, editor.
Rook’s Text Book of Dermatology. Edisi ke-7. Black-Well; 2004: h. 1425-7
Universitas Sumatera Utara
36
19. Verma S, Heffernan MP. Superficial fungal infection. Dalam: Wolf K,
Goldsmith LA, Katz SI, Gilchesrt BA, Paller AS, Leffell DJ, editor.
Fitzpatrick’s Dermatology In General Medicine. Edisi ke-7. New York.
McGraw-Hill Companies Inc; 2008: h. 1807-44.
20. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin
mycoses worldwide. Mycoses 2008; 51 (suppl.4): 2-15.
21. Ryan K. Characteristics of fungi. Dalam: Ryan KJ, Ray GG, editor. Sherris
Medical Microbiology an introduction of infection disease. The McGrawHill Companies; 2004: h. 631-8.
22. Brasch J. Pathogenesis of tinea. JDDG 2010; 8.
23. Romani L. Immunity to fungal infections. Nature Review 2004; 4: h. 1-13.
24. Speth C, Rambach G, Wurzner, Florl CL. Complement and fungal
pathogens : up date. Mycoses 2008; 51: h. 477-96.
25. Gupta KL. Wood’s lamp. Ijdvl 2004; 70 : h.131-5.
26. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P et al. Terbinafine in
the treatment of trichophyton tinea capitis : A randomized, double-blind,
parallel-group, duration-finding study. Pediatrics 2002; 109(4): h. 602-7.
27. Soto-RM, Galimberti R, Suchil. Fluconazole versus ketokonazole in the
treatment of dermatophytoses and cutaneous candidiasis. International
journal of dermatology 1994; 33(10): h. 726-8.
28. Mansour AA. Chronic complication of diabetes in iraq : Experience from
Southern Iraq. Clinical Medicine: Endocrinology and Diabetes 2009; 2: h.19.
29. Manaf A. Thiazolidinediones : Their role in the blood glucose and lipid
control in prediabetes and diabetes. PERKENI. Malang 2007.
30. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN.
Agonist- dependent failur of neutrofil function in diabetes correlates with
extent of hyperglycemia. J Leukocyte Biol 2001; 70: h. 395-404.
31. Szypowska A. Fungal infection in diabetes. Diabetes Research and Clinical
Practice 2007; 86 (1): h. 31-6.
32. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections
in diabetes : pathogenesis, management and relationhip to glycaemic
control. Diabetes Metab Res Rev 2007; 23: h. 3-13.
33. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH.
Perkiraan besar sample. Dalam : Sastroasmoro S, Ismael S, editor. Dasardasar Metodologi Penelitian Klinis. Edisi ke-3. Jakarta : Sagung Seto 2008;
h. 302-30.
34. Notoatmodjo S. Pengantar pendidikan kesehatan dan ilmu perilaku
kesehatan. Edisi ke-3. Jakarta : Rineka Cipta 2007; h. 22-30.
35. Powers CA. Diabetes Melitus. Dalam : Kasper DL, Braunwald E, Fauci AS,
Hauser SL, Longo DN, Jameson JL, editor. Harrison’s Principles of Internal
Medicine. Edisi ke-16. New York : McGraw Hill 2005; 2152-8.
36. Suheyla S. The frequency of superficial fungal infection in patients with
diabetes mellitus and its relation to the level of HbA1c. Turkish J
Endocrinol Metab 1998; 2: 21-3
Universitas Sumatera Utara
37
37.
Ragunatha S, Anitha B, Inamadar C, Palit A, Devarmani SS. Cutaneus
disorders in 500 patients attending diabetic clinic.
38. Arhamni A. Perbandingan derajat keparahan klinis tinea korporis pada
pasien DM tipe 2 terkontrol dengan tidak terkontrol. [tesis]. Medan:
Program magister kedokteran klinik spesialis llmu kesehatan kulit dan
kelamin FK USU, 2013
39. Timshina DK, Thappa DM, Agrawal A. A clinical study of dermatoses in
diabetes to establish its marker. Indian J Dermatol 2012; 57(1): 20-7
40. Romano G, Morreti G, Di Benedetto A, Giofre C, Di Cesare E, Russo G, et
al. Skin lesions in diabetes mellitus : prevalence and clinical correlations.
Diabetes Res Clin Pract 1998; 39(2): 101-6
41. Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneus manifestaion of
diabetes mellitus. J Ayub Med Coll Abbottabad. 2009; 21(2): 76-9
42. Kafaie P, Noorbala MT. Evaluation of onichomycosis among diabetic
patients of yazd diabetic center. Journal of Pakistan Association of
Dermatologists 2010; 20: 217-22
Universitas Sumatera Utara
DAFTAR PUSTAKA
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Perkumpulan Endokrinologi
Indonesia. Konsensus pengelolaan dan
pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PB PERKENI;
2008. h. 4-27.
Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan
Republik Indonesia. Riset Kesehatan Dasar 2007. Jakarta : Departemen
kesehatan RI; 2008
American Diabetes Association, 2004, Diabetes Complications,
www.diabetesjournals.org, 27:1506 – 1514, 8 Maret 2006
Eckhard M, Lenger A, Liersch J, Bretzel RG, Mayser P. Fungal foot
infection in patients with diabetes melitus-results of two independent
investigations. Mycoses 2007; 50 (Suppl. 2): 14-9.
Wani MA, Hassan I, Hayat BM, Ahmed QM. Cutaneus manifestation of
diabetes melitus : A hospital based study in kashmir, India. Edog 2009; 5(2).
Bristow I. Non-ulserative skin pathologies of diabetic foot. Diabetes Metab
Res Rev 2008; 24(Suppl 1): S84–9.
Hadad. Prevalence of cutaneus manifestaion of diabetes melitus. J Ayub
Med Coll Abbottabad 2009; 21(2).
Nasren S, Ahmed I, Jahangir MU. Cutaneus manifestations of diabetic foot.
Journal of pakistan association of dermatologists 2009; 19: 13-7.
Drozdowska A, Drzewoski J. Mycoses in diabetes—Difficult diagnostic and
therapeutic problem. Viamedica 2008; 8(1): 1-11.
Goodall I. HbA1c Standardisation destination—global IFCC standardisation
how, why, where and when. Clin Biochem Rev 2005; 26 (1).
Foss, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J
Am Acad Dermatol 1992; 26: 408-10
Nitin S. HbA1c and factors other than diabetes mellitus affecting. Singapore
Med J 2010; 51(8):616.
Suryaatmaja M. Standarisasi dan harmonisasi pemeriksaan HbA1c. Dalam:
Pendidikan berkesinambungan Patologi klinik 2010. Jakarta: Balai Penerbit
FK UI; 2010. h. 92-104.
Bristow RI, Spruce MC. Short report fungal foot infection, cellulitis and
diabetes : a review. Diabetic Medicine 2009; 26: 548–51.
Akbar N, Bilal N. The sweet foot relation of glycemic control with diabetic
foot lesion. International journal of pathology 2004; 2(2): 90-3.
Haddad F, Khawaldeh AK, Ababneh H, Mai O. Pattern of bacteria and
fungi growth in the non-insulin dependent diabetes melitus toe webs.
Bahrain Med Bull 2008; 20(1): 5-8.
Budi U. Mikosis. Dalam: Djuanda A, Hamzah M, Aisah S, editor. Ilmu
penyakit kulit dan kelamin. Edisi ke-5. Balai Penerbit Fakultas kedokteran
Universitas Indonesia; 2007. h.106-9.
Hay RJ, Moore J. Mycology. Dalam : Burn T, Breathnach S, Cox N, editor.
Rook’s Text Book of Dermatology. Edisi ke-7. Black-Well; 2004: h. 1425-7
Universitas Sumatera Utara
36
19. Verma S, Heffernan MP. Superficial fungal infection. Dalam: Wolf K,
Goldsmith LA, Katz SI, Gilchesrt BA, Paller AS, Leffell DJ, editor.
Fitzpatrick’s Dermatology In General Medicine. Edisi ke-7. New York.
McGraw-Hill Companies Inc; 2008: h. 1807-44.
20. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin
mycoses worldwide. Mycoses 2008; 51 (suppl.4): 2-15.
21. Ryan K. Characteristics of fungi. Dalam: Ryan KJ, Ray GG, editor. Sherris
Medical Microbiology an introduction of infection disease. The McGrawHill Companies; 2004: h. 631-8.
22. Brasch J. Pathogenesis of tinea. JDDG 2010; 8.
23. Romani L. Immunity to fungal infections. Nature Review 2004; 4: h. 1-13.
24. Speth C, Rambach G, Wurzner, Florl CL. Complement and fungal
pathogens : up date. Mycoses 2008; 51: h. 477-96.
25. Gupta KL. Wood’s lamp. Ijdvl 2004; 70 : h.131-5.
26. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P et al. Terbinafine in
the treatment of trichophyton tinea capitis : A randomized, double-blind,
parallel-group, duration-finding study. Pediatrics 2002; 109(4): h. 602-7.
27. Soto-RM, Galimberti R, Suchil. Fluconazole versus ketokonazole in the
treatment of dermatophytoses and cutaneous candidiasis. International
journal of dermatology 1994; 33(10): h. 726-8.
28. Mansour AA. Chronic complication of diabetes in iraq : Experience from
Southern Iraq. Clinical Medicine: Endocrinology and Diabetes 2009; 2: h.19.
29. Manaf A. Thiazolidinediones : Their role in the blood glucose and lipid
control in prediabetes and diabetes. PERKENI. Malang 2007.
30. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN.
Agonist- dependent failur of neutrofil function in diabetes correlates with
extent of hyperglycemia. J Leukocyte Biol 2001; 70: h. 395-404.
31. Szypowska A. Fungal infection in diabetes. Diabetes Research and Clinical
Practice 2007; 86 (1): h. 31-6.
32. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections
in diabetes : pathogenesis, management and relationhip to glycaemic
control. Diabetes Metab Res Rev 2007; 23: h. 3-13.
33. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH.
Perkiraan besar sample. Dalam : Sastroasmoro S, Ismael S, editor. Dasardasar Metodologi Penelitian Klinis. Edisi ke-3. Jakarta : Sagung Seto 2008;
h. 302-30.
34. Notoatmodjo S. Pengantar pendidikan kesehatan dan ilmu perilaku
kesehatan. Edisi ke-3. Jakarta : Rineka Cipta 2007; h. 22-30.
35. Powers CA. Diabetes Melitus. Dalam : Kasper DL, Braunwald E, Fauci AS,
Hauser SL, Longo DN, Jameson JL, editor. Harrison’s Principles of Internal
Medicine. Edisi ke-16. New York : McGraw Hill 2005; 2152-8.
36. Suheyla S. The frequency of superficial fungal infection in patients with
diabetes mellitus and its relation to the level of HbA1c. Turkish J
Endocrinol Metab 1998; 2: 21-3
Universitas Sumatera Utara
37
37.
Ragunatha S, Anitha B, Inamadar C, Palit A, Devarmani SS. Cutaneus
disorders in 500 patients attending diabetic clinic.
38. Arhamni A. Perbandingan derajat keparahan klinis tinea korporis pada
pasien DM tipe 2 terkontrol dengan tidak terkontrol. [tesis]. Medan:
Program magister kedokteran klinik spesialis llmu kesehatan kulit dan
kelamin FK USU, 2013
39. Timshina DK, Thappa DM, Agrawal A. A clinical study of dermatoses in
diabetes to establish its marker. Indian J Dermatol 2012; 57(1): 20-7
40. Romano G, Morreti G, Di Benedetto A, Giofre C, Di Cesare E, Russo G, et
al. Skin lesions in diabetes mellitus : prevalence and clinical correlations.
Diabetes Res Clin Pract 1998; 39(2): 101-6
41. Ahmed K, Muhammad Z, Qayum I. Prevalence of cutaneus manifestaion of
diabetes mellitus. J Ayub Med Coll Abbottabad. 2009; 21(2): 76-9
42. Kafaie P, Noorbala MT. Evaluation of onichomycosis among diabetic
patients of yazd diabetic center. Journal of Pakistan Association of
Dermatologists 2010; 20: 217-22
Universitas Sumatera Utara